{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-22-000010","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2022-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.417828+00:00","generated_at":"2026-06-26T15:43:24.496881+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Charles River Labs appoints Flavia Pease as CFO; David Smith retires to Senior Advisor","bullets":["Flavia Pease named Corporate EVP and CFO effective after Q1 2022 10-Q filing (~early May 2022).","Pease joins from J&J, where she was VP and Group CFO of global Medical Devices ($27B revenue).","Outgoing CFO David Smith will become Senior Financial Advisor until February 2023.","Pease receives $600K base salary, 70% target bonus, $2M equity award, plus $1.7M new-hire equity.","One-time signing bonus of $800,000, with $200K within 30 days and $600K after 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-22-000010","json":"https://secwatch.observer/filing/0001100682-22-000010.json","markdown":"https://secwatch.observer/filing/0001100682-22-000010.md","text":"https://secwatch.observer/filing/0001100682-22-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/crl-20220328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T15:43:24.496881+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"332dda96d5","claim":"Flavia H. Pease was appointed as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"On March 28, 2022, the Company announced the appointment of Flavia H. Pease as its Corporate Vice President and Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Corporate Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"490977c8d8","claim":"David R. Smith retired as Corporate Executive Vice President and Chief Financial Officer at CHARLES RIVER LABORATORIES INTERNATIONAL, INC..","evidence_excerpt":"Mr. Smith will step down from his position as Corporate Executive Vice President and Chief Financial Officer in connection with Flavia H. Pease’s appointment as the Company’s new Corporate Executive Vice President and Chief Financial Officer (as discussed below).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1100682/000110068222000010/0001100682-22-000010-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"retired"},{"label":"Role","value":"Corporate Executive Vice President and Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}